MedPath

Pharmaceutical Companies

Exelixis logo

Exelixis

🇺🇸United States
Ownership
Public
Established
1994-01-01
Employees
1.3K
Market Cap
$7.3B
Website
http://www.exelixis.com
Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was...
Revolution Medicines logo

Revolution Medicines

🇺🇸United States
Ownership
Public
Established
2015-01-01
Employees
378
Market Cap
$7.2B
Website
http://www.revmed.com
Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and...

Bachem AG

🇨🇭Switzerland
Ownership
-
Established
1971-01-01
Employees
-
Market Cap
$7.1B
Website
http://www.bachem.com/
Ownership
-
Established
1947-01-01
Employees
-
Market Cap
$7.1B
Website
https://www.ono.co.jp/

Jazz Pharmaceuticals

🇮🇪Ireland
Ownership
Public
Established
-
Employees
2.8K
Market Cap
$7B
Website
http://www.jazzpharmaceuticals.com
Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product...

Ionis Pharmaceuticals

🇺🇸United States
Ownership
-
Established
-
Employees
927
Market Cap
$7B
Website
-
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core segment. The Ionis Core segment exploits a novel drug discovery platform...

Sinopharm

🇨🇳China
Ownership
-
Established
1998-01-01
Employees
-
Market Cap
$7B
Website
http://www.sinopharm.com
LUNDBECK, LLC logo

LUNDBECK, LLC

🇺🇸United States
Ownership
Subsidiary
Established
-
Employees
-
Market Cap
$6.8B
Website
http://www.lundbeck.com
Grifols logo

Grifols

🇪🇸Spain
Ownership
Subsidiary, Public
Established
1940-01-01
Employees
23.7K
Market Cap
$6.8B
Website
http://www.grifols.com
Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products...
Viking Therapeutics logo

Viking Therapeutics

🇺🇸United States
Ownership
Public
Established
2012-01-01
Employees
27
Market Cap
$6.8B
Website
http://www.vikingtherapeutics.com
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24,...
© Copyright 2025. All Rights Reserved by MedPath